<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">17440311</PMID>
      <DateCompleted>
        <Year>2007</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2013</Year>
        <Month>11</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1042-895X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>30</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2007</Year>
              <Season>Mar-Apr</Season>
            </PubDate>
          </JournalIssue>
          <Title>Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates</Title>
          <ISOAbbreviation>Gastroenterol Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Primary sclerosing cholangitis.</ArticleTitle>
        <Pagination>
          <StartPage>102</StartPage>
          <EndPage>107</EndPage>
          <MedlinePgn>102-5; quiz 105-7</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown origin characterized by progressive inflammation, destruction, and fibrosis of the intrahepatic and extrahepatic bile ducts. The disease leads to obliteration of intrahepatic bile ducts and to biliary cirrhosis, end-stage liver disease, and portal hypertension. Primary sclerosing cholangitis commonly occurs in the presence of inflammatory bowel disease. Its exact etiology remains unknown. As a result, there is no existing effective medical management to delay or modify the progression of the disease. Ursodeoxycholic acid, the most well-studied drug for primary sclerosing cholangitis, has demonstrated promising results when used in combination with an immunosuppressant or antibiotic. To date, liver transplantation remains the only confirmed long-term treatment of primary sclerosing cholangitis, which now accounts for 6% of adult and 1% of pediatric liver transplantations in the United States. Primary sclerosing cholangitis represents an important liver disease with major morbidity and mortality.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Geonzon-Gonzales</LastName>
            <ForeName>Mariben R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Orthopedic Trauma Unit, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. alexgonzales@rcn.com</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Gastroenterol Nurs</MedlineTA>
        <NlmUniqueID>8915377</NlmUniqueID>
        <ISSNLinking>1042-895X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002756">Cholagogues and Choleretics</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>724L30Y2QR</RegistryNumber>
          <NameOfSubstance UI="D014580">Ursodeoxycholic Acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002756" MajorTopicYN="N">Cholagogues and Choleretics</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002758" MajorTopicYN="N">Cholangiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002760" MajorTopicYN="N">Cholangiopancreatography, Endoscopic Retrograde</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015209" MajorTopicYN="N">Cholangitis, Sclerosing</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006975" MajorTopicYN="N">Hypertension, Portal</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008105" MajorTopicYN="N">Liver Cirrhosis, Biliary</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008111" MajorTopicYN="N">Liver Function Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014580" MajorTopicYN="N">Ursodeoxycholic Acid</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>23</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2007</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2007</Year>
          <Month>6</Month>
          <Day>5</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2007</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">17440311</ArticleId>
        <ArticleId IdType="doi">10.1097/01.SGA.0000267929.62298.64</ArticleId>
        <ArticleId IdType="pii">00001610-200703000-00007</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
